Literature DB >> 12184358

Workshop summary. Aluminum in vaccines.

Theodore C Eickhoff1, Martin Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12184358     DOI： 10.1016/s0264-410x(02)00163-9

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  12 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

Authors:  David J Chen; Nikolaus Osterrieder; Stephan M Metzger; Elizabeth Buckles; Anne M Doody; Matthew P DeLisa; David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

Review 3.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

4.  Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.

Authors:  Haiyue Xu; Tinashe B Ruwona; Sachin G Thakkar; Yanping Chen; Mingtao Zeng; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

Review 5.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 6.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

7.  Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.

Authors:  James C King; Yonghong Gao; Conrad P Quinn; Thomas M Dreier; Cabrini Vianney; Eric M Espeland
Journal:  Vaccine       Date:  2015-04-05       Impact factor: 4.169

Review 8.  Aluminum-induced entropy in biological systems: implications for neurological disease.

Authors:  Christopher A Shaw; Stephanie Seneff; Stephen D Kette; Lucija Tomljenovic; John W Oller; Robert M Davidson
Journal:  J Toxicol       Date:  2014-10-02

9.  A review of adjuvants for Leishmania vaccine candidates.

Authors:  Joshua M Mutiso; John C Macharia; Michael M Gicheru
Journal:  J Biomed Res       Date:  2010-01

10.  Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Authors:  Jennifer G Wright; Brian D Plikaytis; Charles E Rose; Scott D Parker; Janiine Babcock; Wendy Keitel; Hana El Sahly; Gregory A Poland; Robert M Jacobson; Harry L Keyserling; Vera A Semenova; Han Li; Jarad Schiffer; Hanan Dababneh; Sandra K Martin; Stacey W Martin; Nina Marano; Nancy E Messonnier; Conrad P Quinn
Journal:  Vaccine       Date:  2013-12-25       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.